Translational Research Centre
Medicine for the Future Today
The TRC, based in Sydney, Australia, is part of the Purecell Group.
The Centre aims to take early to late stage medical and scientific innovations from research and development to commerciality. The TRC, utilizing multidisciplinary teams, can provide a complete or partial set of solutions that accommodate a wide range of client needs at various stops along the translational pathway in Australia.
Innovative Research to Clinical Practice
The TRC’s mission is to accelerate the translation of innovative research across a range of scientific disciplines.
To achieve this, the TRC operates highly skilled and experienced, multidisciplinary teams to develop and implement translationary pathways in a time and cost-effective manner. From KOL connections to leading clinicians, clinical trial facilities and expertise, regulatory and ethics approvals, intellectual property protection, capital acquisition from multiple sources – government grants, venture capital, strategic partner/investors, the TRC has a strong interdisciplinary network of people to adapt to our client’s individual needs.
An End-to-End Solution
The TRC can support and advise early-stage companies developing new therapeutics -in both human and animal fields. These companies may include biologics, cell therapies, medical nanotech, or medical devices.
The Center specializes in taking innovative projects and prototypes from the bench top to the final product.
Utilizing its extensive experience across a wide range of scientific research institutes, therapeutic regulatory requirements as well as clinical trial design and implementation, the TRC can assist clients in the development and commercial translation of a range of medical, veterinary, and scientific products.
0
peer reviewed scientific article
0
Years of industry experience
0
citations
We can help you with
Innovative Projects and Prototypes Assessment - development, formulation, scalability
Small Scale Customized Lyophilization
Access to potential partners/investors -Local and Global. Private and Institutional
Regulatory Hurdles, Ethics Applications, Product Classifications and Registration
Support with Applications for State and Federal Government Grants in Australia
Trial Design and Implementation. Data Collection and Analysis
Intellectual Property – Patents and Licenses- Local and Global
Australian Company Structure and Administration
Connections to Clinicians for Pilot and Commercial Trials- Local and Global
GOVERNANCE
Peter Britton
Chairman
Frank Xu
CEO
Gilles Guillemin
Senior Scientific Advisor
Geoff Barnard
Chief Financial Officer
Australia has a rich history in research discoveries and early-stage translation. However, there is a growing need to develop the MedTech manufacturing capability nationally. RC@PG partners have significant expertise in implementation science and health economics to support evaluation of new evidence into practice.